• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

Quotient Bioresearch (Rushden) Ltd.

Quotient Bioresearch is a leading provider of early stage and specialist drug development services to life science clients worldwide. Formed in early 2007, Quotient initially pursued a buy-and-build strategy and has since been consolidating and integrating the acquired businesses. Quotient has benefitted from significant investment in its facilities in the last few years providing: - One of the world's most extensive bioanalytical facilities, spanning small molecules, biopharmaceuticals, molecular biology and antimicrobials. - A unique approach to early Clinical development, combining expertise in formulation, manufacturing, drug delivery and clinical studies into a single service; and - The world's leading custom radiolabelling facility, including a brand-new GMP facility. Quotient provides tailored solutions for pharmaceutical, biotechnology and agrochemical clients, using state-of-the-art technologies underpinned by unparalleled medical, chemical and biological expertise. These can be provided independently or integrated into bespoke work programmes. *

 

	Start	2010-03-26 existent
	Group	Quotient Bioresearch (Group)
	Industry	genomics
	Region	Rushden, Northamptonshire
	Country	United Kingdom (GB)
	City	n. a. Rushden
		Address record changed: 2012-02-08
Basic data	Employees	n. a.
		* Document for »About Section«: Quotient Bioresearch Ltd.. (1/23/12). "Press Release: Quotient Bioresearch Secures Investment for Next Phase of Growth". Cambridgeshire.
		Record changed: 2012-02-13

More documents for Quotient Bioresearch (Group)

• [1] Quotient Bioresearch Ltd.. (2/2/12). "Press Release: Quotient Achieves Significant Milestones and Consolidates Its Position as a World Leader in 14C Enabled Drug Development"....
• [2] Quotient Bioresearch Ltd.. (1/23/12). "Press Release: Quotient Bioresearch Secures Investment for Next Phase of Growth". Cambridgeshire....
• [3] Quotient Bioresearch Ltd.. (9/19/11). "Press Release: Quotient Bioresearch Announces First Use of Bruker MALDI Biotyper for Bacterial Identification"....
• [4] Quotient Bioresearch Ltd.. (10/12/10). "Press Release: Quotient Bioresearch to Highlight Integrated Early Stage Drug Development Platforms at FIP Pharmaceutical Sciences World Congress 2010". Cambridgeshire, UK....
• [5] Scott Partnership, The. (7/8/10). "Press Release: The Scott Partnership Selected by Quotient Bioresearch to Lead Global PR Campaign". Cheshire....
• [6] Quotient Bioresearch Ltd.. (4/1/10). "Press Release: Quotient Bioresearch Highlights Enhanced Benefits of 14C Radiolabelled Stuides via Expert Webinar Series". Cambridgeshire....
• [7] Quotient Bioresearch Ltd.. (3/26/10). "Press Release: In Vitro Services Expands to Create New Department of In Vitro Sciences"....
• [8] Waters Corporation. (3/9/09). "Press Release: Waters Extends the Power of High Definition Mass Spectrometry for Advanced Scientific Research with Introduction of New Software. DriftScope 2.0 Software Gives Researchers More Discovery Power". Chicago, IL....
• [9] Waters Corporation. (3/9/09). "Press Release: Waters Celebrates Fifth Anniversary of Launch of Award-winning UltraPerformance LC System. After Thousands of Installations, UPLC Fast Becoming the Standard for Separations Science in the Analytical Laborator...

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.